Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.11
-0.39 (-4.11%)
Apr 20, 2026, 12:17 PM EDT - Market open

BioCryst Pharmaceuticals Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
601.84M574.34M531.59M483.04M437.66M404.36M373.72M346.44M
Orladeyo Growth
37.51%42.04%42.24%39.43%34.26%32.21%30.61%28.15%
Other
273.00M25.47M25.92M20.45M13.05M8.22M8.51M8.95M
Other Growth
1,991.62%209.82%204.45%128.43%140.72%-29.82%-58.49%-53.71%

Revenue by Type

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
623.15M593.30M551.63M497.18M442.67M404.06M373.29M345.80M
Product Growth
40.77%46.83%47.78%43.78%36.33%29.50%23.63%20.77%
Collaborative and Other
251.69M6.52M5.88M6.30M8.04M8.52M8.95M9.59M
Collaborative and Other Growth
3,028.87%-23.43%-34.31%-34.31%19.77%53.86%90.65%186.19%

Revenue by Geography

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
146.73M141.56M140.34M120.16M106.97M103.11M95.91M79.97M
United States Growth
37.16%37.28%46.32%50.26%34.68%36.99%31.71%31.42%
Outside of US
53.06M65.32M61.00M56.88M51.70M45.94M43.15M38.97M
Outside of US Growth
2.63%42.17%41.37%45.98%37.39%38.00%50.14%43.94%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.